RIANA Therapeutics GmbH
Developing novel anti-cancer therapies
Back to list
Facts
- Founded
- 08.02.2023
- Staff
- 3
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
- Focus
- human health
Profile
RIANA Therapeutics' approach to drug discovery is based on its proprietary platform technology for discovering compounds that target cancer-promoting protein-protein interactions (PPIs). Using this novel approach, RIANA is searching for inhibitors that block the formation of specific oncogenic PPIs. RIANA is currently working to develop new compounds that specifically target acute myeloid leukemia (AML) as well as other blood cancers and certain types of solid tumors.
Similar companies in RDM biotech/pharma
NGFI Next Generation Fluorescence Imaging GmbH
- Organization type
- RDM biotech/pharma
- Region
- Styria
- Focus
- non-specific applications
Novogenia GmbH
- Organization type
- RDM biotech/pharma
- Region
- Salzburg
- Focus
- non-specific applications
P4 Therapeutics GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Focus
- human health
EveliQure Biotechnologies GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
- Focus
- human health